BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system, with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant transformat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurooncol Adv
Hlavní autoři: Rajani, Karishma, Carlstrom, Lucas, Jacobs, Joshua, Schroeder, Mark, Olson, Ian, Hainy, Matthew, Oh, Juhee, Elmquist, William, Sarkaria, Jann, Burns, Terry
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Supplement Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994322/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab024.019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky